These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28009725)

  • 21. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
    Espinosa A; Alegret M; Pesini P; Valero S; Lafuente A; Buendía M; San José I; Ibarria M; Tejero MA; Giménez J; Ruiz S; Hernández I; Pujadas F; Martínez-Lage P; Munuera J; Arbizu J; Tárraga L; Hendrix SB; Ruiz A; Becker JT; Landau SM; Sotolongo-Grau O; Sarasa M; Boada M; ;
    J Alzheimers Dis; 2017; 57(2):447-459. PubMed ID: 28269787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in cerebrospinal fluid biomarkers for the detection of preclinical Alzheimer's disease.
    Kulic L; Unschuld PG
    Curr Opin Neurol; 2016 Dec; 29(6):749-755. PubMed ID: 27805971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.
    Mazzeo S; Santangelo R; Bernasconi MP; Cecchetti G; Fiorino A; Pinto P; Passerini G; Falautano M; Comi G; Magnani G
    J Alzheimers Dis; 2016 Oct; 54(4):1495-1508. PubMed ID: 27589522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between
    Hammers DB; Atkinson TJ; Dalley BC; Suhrie KR; Beardmore BE; Burrell LD; Horn KP; Rasmussen KM; Foster NL; Duff K; Hoffman JM
    Clin Neuropsychol; 2017 Apr; 31(3):531-543. PubMed ID: 28077020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI.
    Harrington KD; Lim YY; Ellis KA; Copolov C; Darby D; Weinborn M; Ames D; Martins RN; Savage G; Szoeke C; Rowe C; Villemagne VL; Masters CL; Maruff P
    Int Psychogeriatr; 2013 Oct; 25(10):1667-77. PubMed ID: 23866942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down syndrome and Alzheimer's disease: Common pathways, common goals.
    Hartley D; Blumenthal T; Carrillo M; DiPaolo G; Esralew L; Gardiner K; Granholm AC; Iqbal K; Krams M; Lemere C; Lott I; Mobley W; Ness S; Nixon R; Potter H; Reeves R; Sabbagh M; Silverman W; Tycko B; Whitten M; Wisniewski T
    Alzheimers Dement; 2015 Jun; 11(6):700-9. PubMed ID: 25510383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
    Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
    BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinson's and Alzheimer's diseases: Focus on mild cognitive impairment.
    Korczyn AD
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S159-61. PubMed ID: 26516060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.
    Caroli A; Prestia A; Wade S; Chen K; Ayutyanont N; Landau SM; Madison CM; Haense C; Herholz K; Reiman EM; Jagust WJ; Frisoni GB;
    Alzheimer Dis Assoc Disord; 2015; 29(2):101-9. PubMed ID: 25437302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The validity and reliability of the CAMDEX-DS for assessing dementia in adults with Down syndrome in Brazil.
    Fonseca LM; Haddad GG; Mattar GP; Oliveira MC; Simon SS; Guilhoto LM; Busatto GF; Zaman S; Holland AJ; Hoexter MQ; Bottino CM
    Braz J Psychiatry; 2019; 41(3):225-233. PubMed ID: 30365671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preventing cognitive decline in preclinical Alzheimer's disease.
    Riedel WJ
    Curr Opin Pharmacol; 2014 Feb; 14():18-22. PubMed ID: 24565007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
    Iaccarino L; Chiotis K; Alongi P; Almkvist O; Wall A; Cerami C; Bettinardi V; Gianolli L; Nordberg A; Perani D
    J Alzheimers Dis; 2017; 59(2):603-614. PubMed ID: 28671117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychological correlates of amyloid precursor protein in Alzheimer's disease.
    Thomas LD
    Int J Nurs Pract; 1996 Mar; 2(1):29-32. PubMed ID: 9305029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology.
    Margallo-Lana ML; Moore PB; Kay DW; Perry RH; Reid BE; Berney TP; Tyrer SP
    J Intellect Disabil Res; 2007 Jun; 51(Pt. 6):463-77. PubMed ID: 17493029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of machine learning methods for survival analysis of high-dimensional clinical data for dementia prediction.
    Spooner A; Chen E; Sowmya A; Sachdev P; Kochan NA; Trollor J; Brodaty H
    Sci Rep; 2020 Nov; 10(1):20410. PubMed ID: 33230128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Early Mental Test--developing a screening test for mild cognitive impairment].
    Kálmán J; Pákáski M; Hoffmann I; Drótos G; Darvas G; Boda K; Bencsik T; Gyimesi A; Gulyás Z; Bálint M; Szatlóczki G; Papp E
    Ideggyogy Sz; 2013 Jan; 66(1-2):43-52. PubMed ID: 23607229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Memory self-awareness in the preclinical and prodromal stages of Alzheimer's disease.
    Vannini P; Amariglio R; Hanseeuw B; Johnson KA; McLaren DG; Chhatwal J; Pascual-Leone A; Rentz D; Sperling RA
    Neuropsychologia; 2017 May; 99():343-349. PubMed ID: 28385579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer's disease in adults with Down syndrome and mild to moderate learning disabilities.
    Ball SL; Holland AJ; Treppner P; Watson PC; Huppert FA
    Br J Clin Psychol; 2008 Mar; 47(Pt 1):1-29. PubMed ID: 17681112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.